Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Filer	Latest Filing Date	Share-Type	Shares	Market Value	Previously owned	Change
Nea Management Company, Llc	2023-08-11	Shares	34.44M	8.82M	34.44M	0
Nea Management Company, Llc	2023-08-11	Shares	34.44M	8.82M	34.44M	0
Vivo Capital, Llc	2022-11-14	Shares	2.22M	1.76M	2.22M	0
Versant Venture Management,...	2023-08-09	Shares	1.67M	428.80K	1.67M	0
Versant Venture Management,...	2023-08-09	Shares	1.67M	428.80K	1.67M	0
Vivo Capital, Llc	2023-08-14	Shares	0	0	2.22M	-2.22M
Vivo Capital, Llc	2023-08-14	Shares	0	0	2.22M	-2.22M

NASDAQ:UTRS

Minerva Surgical, Inc.

Market Cap

13.14M

Beta: -

Volume Today

1

Avg: 322.31K

PE Ratio

−0.20

PFCF: −0.18

Institutional trades

Institutional Ownership

Current holdings institutionals